Optimal method for measuring baseline metabolic tumor volume in DLBCL patients: are statistical agreements of SUV ≥2.5 satisfactory?
Letter to the Editor
- 4 Downloads
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Research involving human participants and/or animals
- 1.Ilyas H, Mikhaeel NG, Dunn JT, Rahman F, Møller H, Smith D, et al. Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma. Eur J Nucl Med Mol Imaging. 2018. https://doi.org/10.1007/s00259-018-3953-z.
- 3.JCGM. Evaluation of measurement data — Guide to the expression of uncertainty in measurement. 2008. www.bipm.org, September 2008.
© Springer-Verlag GmbH Germany, part of Springer Nature 2018